Data / Form D filings / Impruvon, Inc.
Impruvon, Inc.: Form D filing
Impruvon, Inc., a health care company in Baltimore, MD, filed a Form D with the SEC in 2025. The latest, on February 5, 2025, reports $2.4 million sold of a $2.5 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2101 E. BIDDLE STREET, SUITE J5, Baltimore, MD, 21213
- Phone
- (410) 818-7272
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2052407
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | New notice | $2,499,995 | $2,414,996 | $84,999 | 14 | Nov 6, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Justin Amoyal | Executive Officer, Director, Promoter | |
| Matthew Brezina | Director | |
| Christopher College | Director |
Other health care companies in Maryland that filed recently
- ColoWatch, Inc. /MD/ $1.3 million · Oct 19, 2026
- Aromha, Inc. $75,000 · Sep 24, 2026
- Functional Longevity Labs, Inc. $25,000 · Sep 21, 2026
- Terrace Systems, Inc. $250,000 · Sep 16, 2026
- Savannah Therapeutics, Inc $3.9 million · Sep 11, 2026
- Featherglass Health, Inc. $25,000 · Sep 4, 2026
Every Form D from the week of Feb 3, 2025 · All recent filings in Maryland · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Impruvon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.